Gastroenterologists are medical specialists who diagnose and treat disorders of the digestive system, including the stomach, intestines, liver, and pancreas. Gastroenterologists study and recommend beneficial bacterial strains like Lactobacillus and Bifidobacterium, which help restore gut balance, improve digestion, and support immune function. They often prescribe probiotics for conditions such as irritable bowel syndrome (IBS), inflammatory bowel disease (IBD), antibiotic-associated diarrhea, and small intestinal bacterial overgrowth (SIBO) and focus on how non-digestible fibers, such as inulin and fructooligosaccharides (FOS), enhance the growth of beneficial gut bacteria. By promoting a healthier microbiome, prebiotics contribute to better digestion, improved bowel regularity, and reduced inflammation in the gut. They help diagnose and manage conditions affecting the stomach, intestines, liver, and other digestive organs. Common issues they address include acid reflux, irritable bowel syndrome (IBS), inflammatory bowel disease (IBD), constipation, and liver disorders. They use diagnostic tools such as endoscopy, colonoscopy, and imaging tests to assess digestive function and identify potential concerns.
Emerging research highlights the gut-brain axis—the two-way communication between the gut and the brain. Gastroenterologists are increasingly investigating how probiotics and prebiotics can influence mental health conditions such as anxiety, depression, and stress-related disorders. By modulating gut bacteria, these compounds may affect neurotransmitter production and inflammation levels, potentially offering new therapeutic approaches for mental well-being.
Title : Results from a cross-sectional observational study examining irritable bowel syndrome patients six months after finishing their participation in the ViIBS trial
Jacek Piatek, Calisia University, Poland
Title : Gut microbiome as a driver of healthy ageing
Thi Thu Hao Van, RMIT University, Australia
Title : Treating irritable bowel syndrome patients with a balanced multi-strain synbiotic–results from a multi-center, randomized, double-blind, placebo-controlled clinical trial (the ViIBS trial)
Henning Sommermeyer, Calisia University, Poland
Title : Molecular mechanisms underlying the anti-atherogenic actions of probiotics
Dipak P Ramji, Cardiff University, United Kingdom
Title : Global regulatory trends on the use of probiotics and prebiotics in foods and food supplements
David Pineda Ereno, DPE International Consulting, Belgium
Title : Biochemical profile and nutripotential glimpses of Terminalia arjuna bark extract
Suriyavathana Muthukrishnan, Periyar University, India